This Senate Resolution (SR 39) urges Congress and the Department of Veterans Affairs to maintain current funding levels for ambulance service reimbursements for veterans. It directly affects veterans in New Jersey - 338,012 of whom rely on federal reimbursements to cover ambulance costs averaging $400-$600 per trip. The resolution highlights that proposed funding cuts could create financial barriers for veterans, reduce ambulance services (especially in rural areas with hospital closures), and shift costs to state/local governments without adequate resources. It does not change funding but formally requests federal entities not to reduce existing reimbursement rates.
This bill requires healthcare providers to order bilateral ultrasounds at the same time as mammograms for eligible patients, and mandates that health insurers cover both tests without additional cost-sharing. It directly affects women receiving mammograms (particularly those with dense breast tissue, abnormal results, or specific risk factors like family history) and insurers providing health coverage. The law amends existing coverage requirements to explicitly include concurrent ultrasound testing alongside mammograms, rather than requiring it as a follow-up. This changes how insurers must cover diagnostic breast cancer screening, ensuring both procedures are paid for as part of a single visit. The bill does not alter who qualifies for mammograms but specifies that ultrasounds must be ordered simultaneously when mammograms are prescribed.
This bill requires New Jersey's Commissioner of Human Services to apply for federal Medicaid waivers to fund additional medical training slots focused on behavioral health care. If approved, it directs the Commissioner and the Secretary of Higher Education to create a process for medical education programs (both new and existing) to request and use Medicaid funds for these specific training positions. The bill directly affects graduate medical education programs seeking to expand behavioral health training capacity. It creates a concrete mechanism to leverage federal Medicaid funding for this purpose, without changing existing Medicaid rules. The bill takes effect immediately upon passage.
S 850 establishes a $5 million grant program within New Jersey's Department of Health to help health care professional students repay loans or tuition. The program provides grants to qualified recruitment servicers who partner with hospitals and educational institutions, requiring hospitals to match grant funds at 200% and students to commit to three years of work at partner hospitals. It directly affects health care students (capping assistance at $10,000 yearly or $30,000 total), hospitals providing employment, and recruitment servicers managing the program. The bill specifies eligibility, application requirements, and administrative details for distributing funds to support health care workforce retention.
This bill (S 426) would require New Jersey to provide Medicare health care coverage to all state residents - regardless of age, health, or disability status - expanding the federal program beyond its current eligibility rules. It mandates the state to seek federal waivers from CMS to replace existing health programs (like Medicaid) with universal Medicare coverage, with costs adjusted based on existing Medicare/Medicaid payments. The bill also prohibits private insurers from offering duplicate coverage for services already provided through Medicare. This would apply to anyone domiciled in New Jersey for 30 days prior to applying, starting immediately upon enactment.
This bill increases state funding by $1.5 million for the Center for Great Expectations in Somerset, raising its FY2024 appropriation from $500,000 to $2.0 million. The Center provides safe housing and support services to over 1,000 individuals annually, including homeless or economically marginalized people, pregnant or parenting individuals, and those with mental health or substance use challenges. The additional funds will directly support three key programs: the state's only residential program for adolescents with mental health disorders, an adult residential program for pregnant women, and outpatient mental health/substance abuse services. The bill amends the state's annual budget to adjust the funding line for this specific program.
This bill (S 2144) updates licensing rules for residential substance use disorder treatment facilities in New Jersey. It requires applicants to submit independent financial audits (paid by the applicant) and undergo criminal background checks for all owners or major stakeholders (5%+ ownership), with licensure denied for financial misconduct or convictions involving fraud/dishonesty. The Department of Health must also conduct unannounced facility inspections. These changes directly affect facilities seeking or holding licenses and their owners, aiming to ensure financial accountability and safety through stricter vetting.
This bill limits out-of-pocket costs for asthma inhalers under New Jersey health insurance plans. It requires hospital, medical, and health service plans sold in the state to cover prescribed asthma inhalers with no deductible and capping copayments or coinsurance at $35 per 30-day supply. The law applies to all covered individuals who receive a prescription from a participating doctor or nurse practitioner. Plans may offer lower costs but cannot exceed the $35 limit for this specific coverage.
This bill sets a minimum payment rate for out-of-state hospitals that serve significant numbers of NJ pediatric Medicaid patients. Specifically, hospitals providing care to 10,000+ unique NJ FamilyCare pediatric beneficiaries annually must receive at least 125% of the Medicaid fee-for-service rate from the state where they are licensed. It directly affects qualifying out-of-state hospitals, ensuring they are compensated fairly for services to NJ's pediatric Medicaid enrollees. The change aims to maintain access to care by preventing underpayment that could reduce hospital participation in the program.
S 2894 creates the New Jersey Active Pharmaceutical Ingredient Regulatory Commission to oversee the manufacturing of active pharmaceutical ingredients (APIs) within the state and ensure quality standards for APIs used in New Jersey, regardless of where they're manufactured. The commission, composed of 17 members including pharmaceutical industry experts, state health and economic development officials, and non-voting legislative representatives, will establish manufacturing standards, promote API industry growth using federal funding, and serve as a liaison between the pharmaceutical sector and state/federal governments. It operates independently of the Department of the Treasury despite being allocated there, and will adopt rules under the Administrative Procedure Act to carry out its duties. This bill directly affects pharmaceutical manufacturers in New Jersey and those using imported APIs sold within the state.
